{"id":"W4281741466","doi":"10.1200/jco.2022.40.16_suppl.7510","title":"Zanubrutinib plus obinutuzumab (ZO) versus obinutuzumab (O) monotherapy in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Primary analysis of the phase 2 randomized ROSEWOOD trial.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Obinutuzumab; Phases of clinical research; Follicular lymphoma; Gastroenterology; Surrogate endpoint; Refractory (planetary science); Randomized controlled trial; Surgery; Clinical trial; Lymphoma; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001533633,0.001125283,0.001423766,0.0003267758,0.0001932845,0.0009141053,0.000756475,0.0007150017,0.003368898],"category_scores_gemma":[0.0009070724,0.0004403573,0.001065048,0.0003151904,0.0006478652,0.0007232653,0.0003450515,0.001988045,0.0006185609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009421037,"about_ca_system_score_gemma":0.0008360349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001338579,"about_ca_topic_score_gemma":0.005067936,"domain_scores_codex":[0.999673,0.0001804147,0.00001537226,0.00005133253,0.00002443196,0.00005545365],"domain_scores_gemma":[0.9995802,0.00009165177,0.0001193511,0.00002558633,0.00001677128,0.0001663592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9378259,0.006380533,0.001936082,0.0008503788,0.001243979,0.00006748827,0.0001052327,0.001094801,0.005922901,0.0001726383,0.001661112,0.04273895],"study_design_scores_gemma":[0.8278666,0.1600658,0.006680779,0.00007198701,0.0013162,0.0001072238,0.00005069534,0.001081537,0.0009323775,0.0002191688,0.001587336,0.0000202004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891567,0.005879318,0.0002660899,0.000522605,0.0001641479,0.001258463,0.0006884125,0.00006958617,0.001994594],"genre_scores_gemma":[0.9930884,0.002387032,0.0006399779,0.0005490045,0.0001618673,0.0007879114,0.0006987571,0.00001090812,0.001676233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003368898,"threshold_uncertainty_score":0.01127005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06847802474352627,"score_gpt":0.4077650418084169,"score_spread":0.3392870170648906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}